SEC Form 4/A · accession 0001140361-15-013042
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Mar 16, 2015
Accepted (ET)
Mar 24, 2015 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Mar 16, 2015 | M | 300 | $21.675 | A | 122,656 | D | |
| ResMed Common Stock | Mar 16, 2015 | S | 300 | $69.10 | D | 122,356 | D | |
| ResMed Common Stock | Mar 16, 2015 | M | 5,675 | $15.52 | A | 128,031 | D | |
| ResMed Common Stock | Mar 16, 2015 | S | 5,675 | $69.10 | D | 122,356 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $21.675 | Mar 16, 2015 | M | 300 | D | Oct 1, 2009 | Oct 1, 2015 | ResMed Common Stock | 300 | 0 | D |
| ResMed Common Stock Options | $15.52 | Mar 16, 2015 | M | 5,675 | D | Nov 20, 2009 | Nov 20, 2015 | ResMed Commmon Stock | 5,675 | 41,825 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vest 1/4 annually.